Advertisement
The Insight eNO system measures exhaled nitric oxide (eNO), which is awell-established indicator of airway inflammation and asthma control. TheInsight system is a highly accurate device, expressly designed for thephysician's office. It is non-invasive, safe, easy to use, and providesresults in less than a minute. Apieron's unique biosensor detects traceamounts of nitric oxide molecules in a single human breath utilizing aproprietary technology. Current methods and techniques used to diagnose,monitor and treat asthma are costly, time-consuming and cumbersome. Physicianoffice measurement of eNO is a much-awaited breakthrough in medical technologythat provides physicians with a reliable tool to measure their patients'respiratory inflammation better than ever before. Measurement of eNO has alsobeen shown to optimize medication therapy and improve compliance amongpatients with asthma.
Advertisement
William Berger, M.D., Clinical Professor of Pediatrics, University ofCalifornia, Irvine, and Mission Viejo Medical Center, Mission Viejo,California, stated, "In clinical studies with the Apieron Insight eNO monitor,I found the ability to easily and accurately measure eNO in the physician'soffice to be a major advancement in my care for patients with persistentasthma."
It is estimated that more than 20 million people in the U.S. suffer fromasthma, making it one of the most common and costly of all diseases. In fact,every day in America 40,000 people miss school or work due to asthma and 5,000people go to the emergency room due to an asthma attack. One-quarter of allemergency room visits are asthma related and asthma is the most common chronicchildhood disease.
"We are pleased to offer physicians and their patients a reliable,accurate and affordable asthma measurement and management device," said RichLotti, President and CEO of Apieron, Inc. "We believe this product willimprove the standard of care for patients with asthma enabling physicians tooptimize medical therapy for each patient."
"The availability of simple to use, accurate, and economically feasibleeNO measurement devices now enables physicians to intelligently assess andmanage the key pathologic feature of asthma, airway inflammation," said PeterB. Boggs, M.D., Clinical Professor of Pediatrics and Medicine, LSU School ofMedicine, Shreveport, Louisiana. "Prior to the availability to measure eNO,assessing and managing airway inflammation was, for all practical purposes,little more than a guess! The ability to measure eNO in the physician's officeis 'one giant step' in the care of adults and children with asthma."
The Insight eNO system includes a small desktop monitor with an easy-to-read display, trend analysis capabilities and a user-friendly interface. Thesystem uses disposable, single-use sensors to measure nitric oxide accuratelyand non-invasively in less than a minute. Disposable, single-use breath tubesmake it hygienic and convenient for the user to exhale into the device.Patient data can be stored and maintained in unique patient cards for trendanalysis or downloaded to a printer for insurers' and patients' files.
About Apieron Inc.
Apieron Inc. is a private, venture-backed medical device company based inMenlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for themanagement of asthma. The Apieron biosensor technology platform utilizes apatented technology that allows for the highly sensitive detection of selectedanalytes like eNO. Apieron is committed to collaborating with physicians andpatients to develop innovative medical solutions to improve quality of lifeand standards of care.Refer Ques
